1.Improve effects of aromatase inhibitors on the height of children with short stature
Mengmeng XIA ; Jinbo XIANG ; Jun LUO ; Xiaoxia ZHU
China Pharmacy 2025;36(4):501-506
The primary approach for clinical treatment of short stature (SS) in children is the use of recombinant human growth hormone (rhGH). However, the high cost of treatment and the daily injection frequency place a significant economic and psychological burden on the families of affected children. For SS adolescents who have missed the peak growth velocity period of puberty, the use of rhGH alone is also difficult to significantly increase their final adult height. Numerous studies have shown that aromatase inhibitors (AIs) are effective in improving the height of SS boys, especially the combination therapy of AIs and rhGH, which has a better effect. Although the use of AIs may affect the children’s bones, cognitive function, reproductive system and hormone levels, most of these effects are temporary. Since existing research has not fully elucidated its impact on the pubertal changes of girls, it is necessary to fully weigh the benefits and risks when using AIs to treat SS girls in clinical practice. In the future, it is also necessary to carry out pharmacoeconomic research based on the medical environment of China to evaluate the cost- effectiveness of AIs for SS in children.
2.Progress in clinical application of anti-CD20 monoclonal antibody in refractory nephrotic syndrome in children
Jinbo XIANG ; Guanguo SHEN ; Zheng LI ; Xiaoyan HU ; Tingting CAO ; Ziran XU ; Ting DING ; Jingbo LI
China Pharmacy 2025;36(16):2078-2084
Anti-CD20 monoclonal antibodies for the treatment of refractory nephrotic syndrome (RNS) in children. The first- generation rituximab is the most widely used in clinical practice; it shows definite efficacy in children with RNS, is recommended by guidelines, particularly for achieving a high remission rate in minimal change nephrosis, and can significantly reduce the cumulative use of glucocorticoids and immunosuppressants. The second-generation ofatumumab has potential as an alternative treatment for patients who are intolerant or resistant to rituximab, while the third-generation obinutuzumab has shown efficacy in complex cases such as rituximab resistance or post-transplant recurrence. However, there is still controversy regarding the optimization of rituximab treatment dosage and whether ofatumumab and obinutuzumab offer greater advantages than rituximab for the treatment of RNS in children. The most common adverse reaction induced by anti-CD20 monoclonal antibodies is infusion reactions, and long-term adverse events mainly include increased risks of sustained immunosuppression and infections. Rituximab has significant economic advantages for the treatment of RNS, but additional pharmacoeconomic research based on China’s healthcare environment is needed to evaluate the cost-effectiveness of ofatumumab and obinutuzumab in this population. Given that the current use of ofatumumab and obinutuzumab in this field is considered off-label use, clinical application should only proceed after a rigorous evaluation of the patient’s benefits and risks.
3.Multisystem inflammatory syndrome in children related with COVID-19 infection
Xiaoyan HU ; Jun LUO ; Jinbo XIANG ; Fei SUN
Chinese Journal of Immunology 2024;40(3):668-672,封3-封4
Multisystem inflammatory syndrome in children is a disease related with severe acute respiratory syndrome corona-virus 2 infection,which can involve multiple system damage.Most cases included features of shock,cardiac dysfunction,gastrointestinal symptoms,significantly elevated markers of inflammation and cardiac damage,and positive test results for SARS-CoV-2 by serology.Although its clinical features overlap with Kawasaki disease,it is more likely to occur in older children and adolescents,and most of them need to be treated with intensive care and a variety of immunomodulators.At present,the pathogenesis and long-term prognosis of the disease need to be further studied.
4.Technical points of modular operation and standard procedure for three-port anterior mediastinal thymic disease surgery via subxiphoid approach: Experience of Tangdu Hospital
Jipeng ZHANG ; Yongan ZHOU ; Jinbo ZHAO ; Chenghui JIA ; Xinyao XU ; Guangyu XIANG ; Jiahe LI ; Qiang LU
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2024;31(12):1735-1742
Surgery is an important treatment for the anterior mediastinal disease. With the rapid development of minimally invasive techniques, complete resection of the lesion in most patients with thymic disease can be achieved through thoracoscopic surgery. Practice has proved that the three-port resection of anterior mediastinal thymus disease via the subxiphoid approach is an ideal surgical method for the treatment of anterior mediastinal thymic tumors at present, which has strong popularization and popularity and can benefit the patients. The procedure focuses primarily on the anterior and upper mediastinum and can thoroughly expose the anatomy of the mediastinum and both sides, with minimal intraoperative bleeding, high safety, minimal trauma and postoperative pain, and a short hospital stay. It has clear advantages over conventional thoracic open-heart surgery and transversal resection. However, the surgical approach and field of view, and intraoperative precautions of this procedure are completely different from those of previous thoracoscopic procedures, and from the subxiphoid single-port approach adopted by other centers. Based on 10 years of surgical experience at our center, a modular mode of surgical operation has been developed and its procedure has been standardized. This paper will share and discuss relevant operational points and experiences.
5.Application progress of artificial intelligence in the diagnosis and treatment of scoliosis
Linyi XIANG ; Jinbo ZHU ; Yiting GE ; Xiangxiang PAN
Chinese Journal of Orthopaedics 2022;42(6):388-394
Artificial intelligence (AI), a branch of computer science, is an emerging science used to develop theories, methods, technologies and application systems that can simulate human intelligence. The goal is to enable machines to solve some complex tasks that require human intelligence. With the era of big data coming, AI has been widely used in multitudinous professional fields, including machine vision, speech recognition, image understanding, genetic programming, intelligent factory and expert systems. As the most common three-dimensional deformity of the spine, scoliosis not only changes patients' appearance and body shape but also affects their mental health. Some challenges have to be solved in diagnosis and treatment of scoliosis, such as the complexity of the anatomical structure of the spine, the importance of maintaining the posture, and the long learning-curve of spine specialty. Additionally, some aspects, such as heavy workload, fatigue, high misdiagnosis rate and missed diagnosis rate, are prone to occur in large-scale scoliosis screening and diagnosis. Researchers have discovered that AI can learn inherent laws and representation of sample data in recent years. AI technology has been used in clinical practice, such as screening, diagnosis, surgical decision-making, intraoperative operation, prognosis prediction and conservative interventions. However, AI technology has serious limitations currently. There are many disadvantages in diagnosis and treatment of scoliosis, including irregular data collection, technical difficulty, inherent defects of AI, overdependency on AI, legal and ethics issues. Thus, summarizing the relevant trends and application of AI in the diagnosis and treatment of scoliosis is still required by using the literature database and data-sharing network. The aim of the present review is to provide a glimpse into the future applications of AI.
6.Research progress on growth hormone therapy for idiopathic short stature and growth hormone deficiency complicated by scoliosis
Jinbo ZHU ; Jiasheng HU ; Linyi XIANG ; Xiangxiang PAN ; Chenhang SUN ; Xiangyang WANG
Chinese Journal of Orthopaedics 2022;42(18):1236-1241
Scoliosis is characterized by one or several segments of the spine bending sideways, accompanied by vertebral rotation and sagittal imbalance with complex etiology. Scoliosis can be caused by congenital vertebral abnormalities, asymmetry of the paraspinal muscles due to neurological lesions, and malnutrition or metabolic disorders of bone tissue. Growth hormone is a peptide hormone that plays a key role in promoting human growth and development, especially in bone growth. When the secretion of growth hormone in children or adolescents in the rapid growth stage is insufficient, it may lead to the occurrence of idiopathic short stature (ISS) and growth hormone deficiency (GHD). In clinic, ISS and GHD are mainly treated by recombinant human growth hormone (rhGH). According to some early clinical reports, in the process of rhGH treatment, many patients occur scoliosis or the original scoliosis progression is aggravated. Therefore, many scholars conclude that rhGH treatment of ISS or GHD will lead to the occurrence or development of scoliosis. However, with the increase of clinical statistics and the further progress of research, many scholars found that rhGH treatment of ISS or GHD will only increase the Cobb angle of patients with scoliosis, but will not lead to the occurrence of scoliosis, that is, rhGH treatment of ISS or GHD will not increase the prevalence of scoliosis. At present, whether rhGH treatment of ISS and GHD can lead to scoliosis and aggravation of scoliosis remains controversial. Therefore, this paper summarizes and analyzes the correlation research on the risk of scoliosis complications in children treated with rhGH, and concludes that age, gender, body mass index, and growth potential are risk factors for the development or progression of scoliosis during treatment, and discusses the balance of advantages and disadvantages of using rhGH for ISS or GHD to provide a direction for future clinical guidance.
7.Whole-genome sequencing of SARS-CoV-2 Gamma variant first discovered in Chinese mainland
Jinbo ZHANG ; Xiang LI ; Guoying ZHANG ; Chunping WANG ; Zongyan SUI ; Yu SONG ; Yuwei ZHANG
Chinese Journal of Microbiology and Immunology 2022;42(11):845-850
Objective:To investigate the whole genome of SARS-CoV-2 causing COVID-19 in Rongcheng city of Shandong Province in May 2022 and to further analyze the nucleotide and amino acid variations for source tracing.Methods:High-throughput sequencing was used to sequence the SARS-CoV-2 genome in 15 nasopharyngeal swab samples from COVID-19 cluster infections and three environmental samples related to an aquatic product import company. Whole-genome sequence splicing, variant site analysis and sequence typing were performed on the raw sequencing data using virus sequence and variant analysis software. A phylogenetic tree was constructed by evolutionary analysis software. Epidemiological investigation was used to trace the potential source of infection.Results:Thirteen whole genome sequences of SARS-CoV-2 with the length ranging from 29 653 bp to 29 780 bp were successfully obtained from the nasopharyngeal swab samples. The average sequencing depth was 1 756-6 565 X and the genome coverage was 99.20%-99.63%. The results of Pangolin typing showed that the 13 genomes belonged to the VOC/Gamma (P.1.15) evolutionary branch. Compared with the Wuhan reference strain (NC_045512.2), the 13 genome sequences had 40-41 nucleotide mutation sites. There were 23-24 amino acid variation sites in seven protein domains (ORF1a, ORF1b, S, ORF3a, ORF8, ORF9b and N proteins). Evolutionary analysis showed that the viral sequence was grouped to the same subclade as the reference strain from Argentina (EPI_ISL_4082233).Conclusions:In this study, the whole genome sequences of 13 Gamma variant strains were obtained from COVID-19 cluster infections associated with imported cold-chain aquatic products in Rongcheng city, and the imported seafood from South America in 2021 was found to be the source of the virus in a timely manner. This study provided reference for the SARS-CoV-2 variant analysis and case tracing and also suggested that the survival and transmission ability of SARS-CoV-2 on the surface of cold-chain products should not be underestimated and needed further investigation.
8.Whole-genome sequencing analysis of an imported novel coronavirus omicron BA.2 in Weihai city
Jinbo ZHANG ; Xiang LI ; Qi SUN ; Zongyan SUI ; Shuli SHAO
Chinese Journal of Experimental and Clinical Virology 2022;36(2):131-135
Objective:To identify the genome-wide characteristics and variations of the novel coronavirus 2019(2019-nCoV) by combining high-throughput sequencing and bioinformatics techniques, to type and trace the virus.Methods:Pharyngeal swab sample of one 2019-nCoV infection case imported from Weihai city was selected for 2019-nCoV whole-genome sequence capture and NGS high-throughput sequencing. The obtained sequencing data were sequenced and analyzed using virus mutation analysis software, we classify viruses and build phylogenetic trees to track their potential sources.Results:The complete genome sequence of 2019-nCoV was obtained, with a total length of 29 808 bp and an average sequencing depth of 5 013.11×. A total of 51 nucleotide mutations were found in 8 coding regions (ORF1ab, S, ORF3a, E, M, ORF6, ORF7a and N). The result of virus typing showed that the virus belonged to Omicron BA.2. Evolutionary analysis showed that the virus sequence was in the same clade as the reference strains from Japan.Conclusions:The sequencing method and analysis result established in this study can be used for mutation analysis of 2019-nCoV and case tracing, which is of great significance for the prevention and control of COVID-19.
9.Solution structure of the RNA recognition domain of METTL3-METTL14 N-methyladenosine methyltransferase.
Jinbo HUANG ; Xu DONG ; Zhou GONG ; Ling-Yun QIN ; Shuai YANG ; Yue-Ling ZHU ; Xiang WANG ; Delin ZHANG ; Tingting ZOU ; Ping YIN ; Chun TANG
Protein & Cell 2019;10(4):272-284
N-methyladenosine (mA), a ubiquitous RNA modification, is installed by METTL3-METTL14 complex. The structure of the heterodimeric complex between the methyltransferase domains (MTDs) of METTL3 and METTL14 has been previously determined. However, the MTDs alone possess no enzymatic activity. Here we present the solution structure for the zinc finger domain (ZFD) of METTL3, the inclusion of which fulfills the methyltransferase activity of METTL3-METTL14. We show that the ZFD specifically binds to an RNA containing 5'-GGACU-3' consensus sequence, but does not to one without. The ZFD thus serves as the target recognition domain, a structural feature previously shown for DNA methyltransferases, and cooperates with the MTDs of METTL3-METTL14 for catalysis. However, the interaction between the ZFD and the specific RNA is extremely weak, with the binding affinity at several hundred micromolar under physiological conditions. The ZFD contains two CCCH-type zinc fingers connected by an anti-parallel β-sheet. Mutational analysis and NMR titrations have mapped the functional interface to a contiguous surface. As a division of labor, the RNA-binding interface comprises basic residues from zinc finger 1 and hydrophobic residues from β-sheet and zinc finger 2. Further we show that the linker between the ZFD and MTD of METTL3 is flexible but partially folded, which may permit the cooperation between the two domains during catalysis. Together, the structural characterization of METTL3 ZFD paves the way to elucidate the atomic details of the entire process of RNA mA modification.
10.Analysis of drug resistance and risk factors of methicillin-resistant Staphylococcus aureus in pediatric wards
Xing WEI ; Yinhuan DING ; Chengyu XIANG ; Lian LIU ; Lan ZHENG ; Jinbo LIU
International Journal of Laboratory Medicine 2018;39(11):1311-1314
Objective The drug resistance and risk factors of methicillin resistant Staphylococcus aureus (MRSA) infected in the pediatric ward of the hospital were analyzed to provide a scientific basis for the con-trol of MRSA paediatric infection .Methods Totally 306 strains of Staphylococcus aureus were isolated from the pediatric wards in the Affiliated Hospital of Southwest Medical University from July 2015 to June 2016 , the bacterial species identification and drug susceptibility tests were performed by MicroScan WalkAway 96SI and the statistical analysis was carried out by WHONET 5 .4 softwate .The clinical data of 306 children were infected with staphylococcus aureus collected by retrospective survey ,the risk factors of MRSA infection were analyzed by the method of χ2 test and non-condition Logistic regression .Results A total of 90 strains of M R-SA were detected ,with a detection rate of 29 .41% .MRSA was mainly isolated from sputum ,accounting for 74 .44% ,followed by blood ,accounting for 10 .0% .MRSA was mainly resistant to amikacin ,ampicillin ,eryth-romycin ,clindamycin and other antimicrobial agents (P< 0 .05) .Age< 1 years ,venous catheterization ,me-chanical ventilation ,tracheal intubation ,ventilator ,stay in ICU ,hospitalization time >7 d ,use of corticoste-roids ,low albumin ,and antibiotic use time >7 d were the main risk factors of MRSA in children (P<0 .05) . Admission to NICU ,venous catheterization ,mechanical ventilation and tracheal intubation were independent risk factors .Conclusion MRSA isolated from pediatric wards is resistant to many kinds of antibiotics .Infec-tion with MRSA is related to many factors .Hospitals should take corresponding measures to reduce the inci-dence of M RSA infection .

Result Analysis
Print
Save
E-mail